Remove Analysis Remove Applied Research Remove Briefing Remove Competitive
article thumbnail

U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment

ArchIntel

While the demand seemingly outpaces the industry’s ability to produce treatments for the pandemic, the quest to develop the “silver bullet” against COVID-19 is expected to drive competition in the industry. This fierce competition is predicted to propel the U.S. Volkan Gunduz, Associate Director of CI, Sanofi Genzyme.

article thumbnail

Competitor highlights: Leidos

FedSavvy

Brief History of Mergers and Acquisitions. Figure 1 – A brief history of Leidos acquisitions and sales. Dynetics December 2019 Applied research and national security solutions business that provides hypersonics, space, and weapons solutions. Figure 2 – Recent and very visible acquisitions made by Leidos.

Briefing 130